ID: ALA4872604

Max Phase: Preclinical

Molecular Formula: C35H43N4O6P

Molecular Weight: 646.73

Molecule Type: Unknown

Representations

Canonical SMILES:  CC(C)C[C@H](CP(=O)(O)[C@H](CCc1ccccc1)NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O

Standard InChI:  InChI=1S/C35H43N4O6P/c1-24(2)19-28(34(41)38-31(33(36)40)20-27-21-37-30-16-10-9-15-29(27)30)23-46(43,44)32(18-17-25-11-5-3-6-12-25)39-35(42)45-22-26-13-7-4-8-14-26/h3-16,21,24,28,31-32,37H,17-20,22-23H2,1-2H3,(H2,36,40)(H,38,41)(H,39,42)(H,43,44)/t28-,31+,32-/m1/s1

Standard InChI Key:  KZIIFGMGKICFJK-FZPFXXBJSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 646.73

Molecular Weight (Monoisotopic): 646.2920

AlogP: 5.50

#Rotatable Bonds: 16

Polar Surface Area: 163.61

Molecular Species: ACID

HBA: 5

HBD: 5

#RO5 Violations: 2

HBA (Lipinski): 10

HBD (Lipinski): 6

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 1.55

CX Basic pKa:

CX LogP: 4.95

CX LogD: 2.57

Aromatic Rings: 4

Heavy Atoms: 46

QED Weighted: 0.10

Np Likeness Score: -0.01

References

1. Wilding B, Pasqua AE, E A Chessum N, Pierrat OA, Hahner T, Tomlin K, Shehu E, Burke R, Richards GM, Whitton B, Arwert EN, Thapaliya A, Salimraj R, van Montfort R, Skawinska A, Hayes A, Raynaud F, Chopra R, Jones K, Newton G, Cheeseman MD..  (2021)  Investigating the phosphinic acid tripeptide mimetic DG013A as a tool compound inhibitor of the M1-aminopeptidase ERAP1.,  42  [PMID:33887439] [10.1016/j.bmcl.2021.128050]

Source

Source(1):

• Scientific Literature